Epix to cut work force, narrow research focus

10/23/2008 | AuntMinnie.com (free registration)

Epix Pharmaceuticals has announced plans to slash its work force by 23% and reduce its research and development focus in order to cut costs. The contrast-agent developer said it will concentrate on developing PRX-03140 for Alzheimer's disease and PRX-08066 for chronic obstructive pulmonary disease but will continue plans to market its Vasovist MRI contrast agent.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC